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ABSTRACT 
Migraine is a neurologic disorder that causes impairment in many areas of functioning. Migraine 
sufferers frequently avoid environmental stimuli (triggers) they assume to be associated with 
migraine onset, which may inadvertently lead to an increase in the potency of some triggers and 
increase headache frequency over time. Headache patients who instead use acceptance strategies 
to limit their attempts to control or eliminate/avoid their pain may experience reduced distress 
and pain-related disability. Studies examining acceptance-based approaches in managing chronic 
pain conditions have shown favorable results of acceptance on pain intensity, reduced pain-
related anxiety and avoidance, and less physical and psychological disability. However, few 
studies have examined the construct of acceptance among individuals with headache. In order to 
extend previous research on chronic pain conditions, the purpose of the present study was to 
investigate the relationship between psychological acceptance and headache-related variables 
among young adults, a population at increased risk for headache but typically without 
complications posed by long headache histories and medication overuse.  The sample consisted 
of 2,005 individuals (65% female; mean age = 19.10 years [SD = 2.27]): 839 without headache 
(42%), 602 with migraine (30%), and 564 with tension-type headache (28%). Acceptance scores 
distinguished among headache diagnostic groups such that those with lower acceptance were 
those with more frequent and severe headache disorders. Acceptance explained 10% of the 
variance (p < 0.001) in headache-related disability and 5% of the variance in both headache 
severity (p < 0.001), and headache frequency (p < 0.001). These proportions were much smaller 
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but statistically significant after controlling for gender and comorbid psychiatric symptoms. 
Although negative associations between acceptance and the headache variables was observed, 
these were rather modest and indicate that the role of acceptance in headache may be different 
than originally hypothesized. Limitations and future directions are discussed.  
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INTRODUCTION 
 
PRIMARY HEADACHE DISORDERS 
Headache disorders are prevalent and a common cause of significant disability (Stovner 
et al., 2007). The International Classification of Headache Disorders (ICHD-2; Headache 
Classification Committee of the International Headache Society, 2004) classifies headaches not 
attributable to other disorders as primary headaches, which include migraine and tension-type 
headache (TTH). A recent meta-analytic review observed a 66% worldwide lifetime prevalence 
rate for headache in the general population (Stovner et al.), although precise rates by disorder 
vary as a function of gender and ethnicity.  
Migraine is a neurological disorder characterized by recurrent attacks of severe head pain 
and associated symptoms (Headache Classification Committee of the International Headache 
Society, 2004). The lifetime prevalence of migraine is 10-12% in the general population (Jette, 
Patten, Williams, Becker, & Wiebe, 2008; Lipton et al., 2007; Radtke & Neuhauser, 2009; 
Stovner et al., 2007). Migraine is three times more common among women than men (15-18% vs. 
5-6%) and is often viewed as a women’s health issue (Radtke & Neuhauser; Lipton et al.). 
Migraine occurring 15 or more days per month is classified as chronic migraine (CM; Lipton, 
Scher, Silberstein, & Bigal, 2008; Headache Classification Committee of the International 
Headache Society, 2004). The prevalence of migraine is highest among Caucasian Americans 
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and tends to be the lowest among Asian and African Americans (Lipton, Bigal, Hamelsky, & 
Scher, 2008).  
Migraine occurs with specific symptoms distinguishable from those of other headache 
subtypes. The disorder is characterized by the experience of recurrent headache lasting 4-72 
hours if untreated or unsuccessfully treated and must have at least two of the following 
characteristics: unilateral location, pulsating pain quality, moderate to severe pain intensity, and 
aggravation by routine physical activity. Migraine also requires nausea and/or vomiting and/or 
sensitivity to both light (photophobia) and sound (phonophobia; Headache Classification 
Committee of the International Headache Society, 2004).  
Migraine has been ranked by the World Health Organization (WHO) among the top 20 
diseases worldwide that cause significant disability (Leonardi, Steiner, Scher, & Lipton, 2005; 
World Health Organization, 2001). Because of its cyclical and often chronic nature, migraine 
contributes to significant functional impairment spanning occupational, academic, social, and 
family aspects of life (Buse, Rupnow, & Lipton, 2009; Clarke, MacMillan, Sondhi, & Wells, 
1996; Dowson & Jagger, 1999; Leonardi et al.; Linde & Dahlöf, 2004). Compared to non-
migraineurs, four times as many migraineurs report frequent disability (>12 days of not being 
able to perform usual work or everyday activities) resulting from headache (Radtke & Neuhauser, 
2009). Lipton et al. (2007) demonstrated that over 50% of migraineurs report severe impairment 
or require bed rest during their headaches. Migraine is also associated with cognitive deficits 
such as problems with concentration, comprehension and communication, and both short- and 
long-term memory impairment (Sas, Arpad, Jozsef, & Vecscei, 2010). Although migraine occurs 
at high rates and is associated with significant disability and impairment in daily functioning, 
TTH is even more prevalent and also contributes to significant functional impairment.  
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Tension-type headache is the most common primary headache disorder among the 
general population, with a global lifetime prevalence of 46% (Stovner et al., 2007; Lodner & 
Rizzoli, 2008; Rasmussen, Jensen, Schroll, & Olesen, 1991; Rasmussen, 1995; Schwartz, 
Stewart, Simon, & Lipton, 1998; Lyngberg, Rasmussen, Jorgensen, & Jensen, 2005). TTH has 
three subtypes that include infrequent episodic TTH (ETTH) that occurs less than once per 
month, frequent ETTH that occurs between 1-14 days per month, and chronic TTH (CTTH) that 
occurs 15 or more days per month (ICHD-II; Lenaerts & Newman, 2008). Prevalence of TTH is 
higher among Caucasian Americans (43%) than African-Americans (26%), increases with 
education level, and peaks in the 30 to 39 year-old age group for both men and women (42% and 
47%, respectively; Schwartz et al.).  
Tension-type headache occurs with symptoms typically opposite to those of migraine. 
Compared to migraine, TTH pain severity tends to be mild to moderate. Tension-type headaches 
are characterized by recurrent attacks lasting 30 minutes to 7 days with at least two of the 
following characteristics: bilateral location, pressing/tightening (non-pulsating) pain quality, 
mild or moderate pain intensity, and non-aggravation by routine physical activity; an absence of 
associated nausea or vomiting is also required (Headache Classification Committee of the 
International Headache Society, 2004). Disability and impairment in functioning are also 
associated with TTH, such that 8% of ETTH sufferers report lost workdays due to their 
headaches, while 44% report decreased effectiveness at work, home, or school (Schwartz, 
Stewart, Simon, & Lipton, 1998). Further, CTTH sufferers report higher levels of daily life stress 
than non-headache controls (Holroyd et al., 2000). In their study examining correlates of CTTH, 
Holroyd and colleagues observed that CTTH was frequently associated with impairments in 
physical (62%), social (57%), and occupational functioning (60%).  
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Psychiatric Comorbidities and Headache 
 Both migraine and TTH are associated with co-occuring psychiatric disorders (Breslau, 
1998; Breslau & Davis, 1992; Juang, Wang, Fuh,  Lu, & Su, 2000; Puca et al., 1999), which 
compound the burden of these headache disorders. Migraine is associated particularly with major 
depressive disorder, generalized anxiety disorder, panic disorder, social phobia, and bipolar 
disorder (Baskin, Lipchik, & Smitherman, 2006; Breslau; Breslau & Davis; Breslau & Davis, 
1993; Breslau, Lipton, Stewart, Schultz, & Welch, 2003; Breslau, Shultz, Stewart, Lipton, & 
Welch, 2001; Hamelsky & Lipton, 2006; Swartz, Pratt, Armenian, Lee, & Eaton, 2000; Wang, 
Chen, & Fuh, 2010). Specifically, individuals with migraine are 2-3 times more likely to suffer 
from depression and 3-5 times more likely to suffer from anxiety disorders compared to 
individuals without migraine (Breslau; Breslau, Davis, Schultz, & Peterson, 1994; Hamelsky & 
Lipton).  
Extant literature has more clearly delineated the relationship between migraine and 
associated psychiatric disorders. Recent research has revealed a bidirectional relationship 
between migraine and depression, indicating that the presence of either disorder increases risk of 
onset for the other (Breslau et al., 1994; Breslau, 1998; Breslau et al., 2000; Breslau et al., 2003). 
Similarly, a bidirectional relationship has been implicated between migraine and panic disorder 
(Breslau et al., 2001). These bidirectional relationships are potentially suggestive of shared 
etiological pathways between migraine and affective disorders (Breslau; Breslau et al.), although 
the underlying mechanisms remain unclear (Baskin et al., 2006; Baskin & Smitherman, 2009). 
Baskin and Smitherman suggest that medication overuse, serotonergic dysfunction, hormonal 
fluctuations, and processes related to central nervous system sensitization are likely mechanisms. 
Despite uncertainty on shared etiological mechanisms between migraine and psychiatric 
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comorbidity, these comorbidities are associated with reduced satisfaction with acute migraine 
treatment, perceived efficacy of treatment, and headache-related quality of life; increased 
medication overuse; and increased migraine-related disability (Lanteri-Minet, Radat, Chautard, 
& Lucas, 2005). These findings suggest that the impact of migraine may be reduced if 
interventions also address psychiatric symptomatology.   
Similar to migraine, TTH is associated with multiple psychiatric disorders including 
depressive and anxiety-related disorders. In a large Italian sample, Puca and colleagues (1999) 
found that 51% and 21% of ETTH sufferers met criteria for anxiety and depressive disorders, 
respectively. This study found CTTH sufferers to be at higher risk for psychiatric comorbidities 
than ETTH sufferers, paralleling other findings that higher frequency headache is associated with 
highest rates of psychiatric disorders (Juang et al., 2000; Mongini et al., 2006). Puca and 
colleagues observed that 56% of CTTH patients experienced comorbid anxiety disorders and 
45% had comorbid depressive disorders. Generalized anxiety disorder (45%) emerged as the 
most common anxiety disorder and dysthymia (17%) as the most common mood disorder. The 
authors cautioned that patients were recruited from tertiary care headache centers and results 
may only generalize to those with more severe or chronic TTH. Other studies have suggested 
that female gender is particularly associated with depressive disorders among CTTH patients 
(Juang et al.). Collectively, these findings suggest that psychological factors are particularly 
relevant among individuals with both migraine and CTTH.   
Coping styles of headache sufferers. In addition to psychiatric disorders, headache is 
also influenced by other psychological factors including precipitating variables and maladaptive 
coping styles. Behavioral responses to trigger factors and other headache-related stimuli differ 
across headache diagnostic groups. For instance, migraineurs are more likely to avoid noise, light, 
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social activity, and physical activity compared to tension-type headache patients (Scharff, Turk, 
& Marcus, 1995), likely because these factors aggravate migraine but not TTH. However, when 
headache severity is taken into account, these differences in behavioral responses dissipate 
(Scharff et al.). Some coping responses are associated with increased headache-related disability 
(Ford, Calhoun, Kahn, Mann, & Finkel, 2008). For example, in migraineurs, coping behaviors 
such as lying down, social withdrawal, negative self-statements, reliance on negative thoughts, 
wishful thinking, and self-criticism are particularly associated with increased headache intensity, 
vomiting, and nausea (Ford et al.; Hassinger, Semencuk, & O’Brien, 1999). Headache pain is 
also influenced by behavioral techniques employed to alleviate pain.  
 Migraineurs and TTH sufferers employ many nonpharmacological, or behavioral, 
techniques to cope with pain directly. In a study examining the use of nonpharmacological 
abortive measures by headache patients, Martins and Parreira (2001) found that migraineurs 
engaged in more behaviors to reduce headache pain and its associated symptoms than TTH 
sufferers. Frequently-used behaviors were pressing and applying cold stimuli to the painful site, 
trying to sleep, changing posture, sitting or reclining in bed, isolation, using symptomatic 
medication, inducing vomiting, and dietary changes. Migraineurs reported more relief than TTH 
sufferers when they used symptomatic medications, isolation, applied local pressure, and used 
local cold pads. Although pain relief is not always attained, these findings suggest that headache 
sufferers employ many strategies to alleviate the pain and symptoms associated with their 
headaches (Martins & Parreira).  
Experiental avoidance and avoidant coping. Humans use cognitive and affective 
strategies to avoid unpleasant private experiences (i.e., thoughts, bodily sensations, emotions, 
and memories; Chawla & Ostafsin, 2007). Experiential avoidance denotes an unwillingness to 
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remain in contact with aversive private events, typically involving the rigid and inflexible 
application of escape/avoidance strategies to control the form or frequency of these events (Costa 
& Pinto-Gouveia, 2011; Hayes, Wilson, Gifford, Follette, & Strosahl, 1996). Avoidant coping 
through evading environmental stimuli or suppressing thoughts/emotions thus represents a means 
of experiential avoidance. Avoidant coping is associated with negative psychological outcomes 
such as increased psychiatric disorder symptomatology (Chawla & Ostafsin) and psychological 
distress (Aldwin & Revenson, 1987). 
Many of the aforementioned coping strategies used by headache patients are 
characterized as avoidance strategies (e.g., lying down, social withdrawal) and are associated 
with the exacerbation of headache pain and related symptoms (Ford et al., 2008; Hassinger, 
Semencuk, & O’Brien, 1999). Existing data also suggests that both migraineurs (Hassinger et al.) 
and TTH sufferers (Holm, Holroyd, Hursey, & Penzien, 1986) more commonly use avoidant 
coping strategies to manage stress and pain than do individuals without headache. In fact, many 
headache patients are counseled by their providers to avoid triggers putatively associated with 
onset of their migraines. Furthermore, both migraineurs and TTH sufferers exhibit increased 
maladaptive coping behaviors and psychiatric symptoms during headache episodes (i.e. 
avoidance of social and physical activity, more helplessness and hopelessness, and elevated 
depression and anxiety; Siniatchkin, Riabus, & Hasenbring, 1999).  
Recently, evidence has emerged suggesting associations between avoidant coping and 
poor psychological outcomes. A recent study investigating the mediating effect of experiential 
avoidance between coping and psychopathology in a chronic pain sample found that low 
utilization of adaptive coping strategies was associated with psychopathology through 
differences in processes pertaining to psychological inflexibility (i.e., the rigid dominance of 
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stereotyped reactions to stimuli across various situations; Bond et al., 2011), of which 
experiential avoidance is one. Chronic pain patients who utilized more adaptive coping strategies, 
however, exhibited less depression and stress. The authors suggest that chronic pain patients may 
achieve better psychological outcomes if they reduce their avoidance and pain-control strategies 
(Costa & Pinto-Gouveia, 2011). Beyond attempts to avoid pain per se, headache sufferers also 
employ avoidant strategies to cope with precipitating variables associated with headache onset.  
Avoidance of headache triggers. Martin and Macleod (2009) define headache triggers 
as precipitating factors that precede the headache attack within 48 hours. Some of the most 
commonly reported triggers include: stress and negative emotions, hormonal factors for females, 
noise, odors, hunger, certain foods and alcohol, weather, fatigue, and lack of sleep (Kelman, 
2007; Martin & Macleod). Schulman and Silberstein (1992) noted the importance of identifying 
headache triggers and advised practitioners to help patients avoid these triggers. Furthermore, 
Skaer (1996) maintained that the prevention of migraines was best attained by avoiding 
precipitating migraine triggers. 
 Recently, however, the wisdom of counseling patients to avoid triggers has been 
challenged, as a review by Martin and Macleod (2009) suggested that avoidant coping strategies 
may ultimately actually increase the potency of some triggers, contributing to more frequent 
headaches and potentially headache chronification. Specifically, Martin (2000; 2001) found that 
exposing headache patients to visual stimuli associated with headache onset resulted in 
desensitization of the associated stimuli, less negative affect, and less head pain in response to 
the trigger subsequently. Similarly, Philips and Jahanshahi (1985) observed that exposure to 
noise associated with headache onset reduced pain behavior, whereas avoidance of the trigger 
was associated with increased intolerance. Martin, Reese, and Forsyth (2006) replicated these 
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findings using noise as a trigger, contending that exposure to this trigger may be helpful so long 
as it is not for too long or at too high a level. In light of these accumulating studies, Martin and 
Macleod argued against avoiding triggers and deem it an ineffective strategy for coping with 
headaches. The researchers contended that headache sufferers should engage in 
approach/exposure strategies, to the extent feasible, to manage pain by facilitating 
desensitization of headache triggers (Martin & Macleod). One such approach consistent with 
Martin and Macleod’s therapeutic contention is the psychological construct of “acceptance.” 
Acceptance 
Acceptance is a psychological construct defined by Hayes and colleagues (1996) as the 
active contact (non-avoidance) with psychological experiences while behaving effectively in 
congruence with one’s values. Instead of focusing on often counterproductive attempts to change 
or control undesirable psychological experiences, acceptance-based approaches target more 
readily changeable domains such as overt behaviors or life situations (Hayes et al.). Specifically, 
acceptance-based treatments involve changing individual’s experiences with psychological 
events, instead of attempting to change the psychological event itself. Hayes and colleagues 
described acceptance-based treatments as those that attempt to change the impact of private 
psychological experiences (e.g, emotions and cognitions) by reducing one’s struggle to change 
the “form, frequency, or situational sensitivity” (p. 1163) of these private experiences. While 
initially conceptualized in relation to psychiatric disorders, more recently the construct of 
acceptance has garnered significant attention regarding its relevance to chronic pain.  
Acceptance and chronic pain. Acceptance of pain involves behaving in a way that 
reduces attempts to avoid or control pain (McCracken, 1998; McCracken, Vowles, & Eccleston, 
2004). McCracken described acceptance of pain as acknowledging the presence of pain, 
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abandoning counterproductive attempts to control pain, and being able to commit behavioral 
efforts to living a satisfying life despite pain. Acceptance of pain has been associated with 
positive long-term patient functioning (McCracken & Eccleston, 2005; McCracken & Vowles, 
2008), such that chronic pain patients who are able to pursue their goals and values despite their 
pain are less distressed and disabled by their pain than individuals who persist in 
controlling/avoiding their pain (McCracken et al.). These findings suggest that acceptance may 
be integral to reducing pain-related disability, even if pain itself remains unaltered.  
Studies examining acceptance of pain demonstrate acceptance to be associated with 
lower pain intensity, less pain related anxiety and avoidance, less physical and psychological 
disability, more daily uptime, and better work status (McCracken, 1998; McCracken & Eccleston, 
2003; McCracken, Spertus, Janeck, Sinclair, & Wetzel, 1999). McCracken et al. (2004) found 
that chronic pain patients high on pain acceptance reported lower pain intensities than 
individuals low on pain acceptance, concluding that integrating acceptance into clinical practice 
may be a valuable treatment approach. These studies included primarily patients with chronic 
musculoskeletal pain conditions such as lower back, lower limb, cervical, upper extremities, and 
thoracic region pain. Patients with head and face pain comprised a minuscule proportion 
(approximately 4%) of these samples (McCracken; McCracken & Eccleston). Thus, although 
acceptance-based approaches have garnered strong indication for the treatment of chronic 
musculoskeletal pain conditions (Wetherell et al., 2011; Wicksell, Dahl, & Olsson, 2005), few 
studies have examined the role of acceptance among headache samples.  
In addition to acceptance of pain specifically, general psychological acceptance has also 
been investigated in relation to physical and psychosocial functioning among chronic pain 
samples (McCracken & Zhao-O’Brien, 2010; McCracken & Velleman, 2010). As with 
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acceptance of pain, general acceptance is negatively associated with pain-related distress, 
depression, pain-related anxiety, and physical and psychosocial disability (McCracken & Zhao-
O’Brien). Furthermore, McCracken and Velleman observed general acceptance to increase with 
age in patients with chronic pain. Importantly, general psychological acceptance is a significant 
predictor of patient functioning uniquely of pain acceptance more specifically (McCracken & 
Zhao-O’Brien). These findings indicate that, among chronic pain samples, general acceptance is 
a meaningful psychological construct that independently accounts for variance in patient 
functioning and disability.  
Acceptance and headache.  Although not frequently studied among headache patients 
specifically, acceptance appears to be a psychological construct relevant also to the experience of 
migraine pain. Chiros (2007) found that higher levels of pain-related acceptance were associated 
with lower catastrophizing and pain-related interference with migraineurs’ daily functioning, as 
well as with higher activity and the use of fewer daily coping strategies (Chiros; Chiros & 
O’Brien, 2011). Thus far, however, only two treatment studies have investigated the relationship 
between headache and acceptance, both of which suggest that promoting acceptance is 
associated with better patient functioning and outcomes. 
Acceptance and Commitment Therapy (ACT) is an evidence-based behavior therapy that 
integrates acceptance and mindfulness strategies with behavioral change approaches (Hayes, 
2004; Hayes, Strosahl, & Wilson, 1999). In a recent study examining the effectiveness of a one-
day ACT and migraine education (ACT-ED) workshop, significant improvements were observed 
in patients’ depressive symptoms, general functioning, and migraine-related disability compared 
to a wait list/treatment as usual group (TAU; Dindo, Recober, Marchman, Turvey, & O’Hara, 
2012). The ACT-ED group received one hour of education about migraine (i.e., migraine 
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pathology, risks for migraine chronification, migraine triggers, treatment of migraine, medication 
overuse migraine, and contributing lifestyle factors) and four hours of ACT education. The ACT 
education component focused on teaching patients how to recognize ineffective patterns of 
behavior, exploring and setting life and health-related goals, and promoting effective and 
committed action to achieve these goals (Dindo et al.). This study demonstrated that relative to 
TAU, the ACT intervention was associated with increased general functioning, less headache-
related disability, and reductions in depressive symptomatology, although the inclusion of 
migraine education and lack of a viable comparison condition are limitations.  
In order to examine the effectiveness of ACT in reducing headache-related pain, 
disability, and distress, Mo’tamedi, Rezaiemaram, and Tavallaie (2012) implemented a group-
administered ACT intervention among an Iranian, female sample with chronic migraine and 
CTTH. Mo’tamedi and colleagues utilized a randomized pre-test post-test design with an ACT 
treatment group and a TAU group. In addition to TAU, participants in the ACT group received 
weekly ACT sessions for 8 weeks. The ACT sessions entailed specific goals such as discussing 
difficulty in controlling pain sensations, improving engagement in activities despite pain, 
decreasing avoidant behaviors, identifying and engaging in personally relevant valued action, 
and improving mindfulness. They found that ACT significantly reduced disability and affective 
distress, but not pain itself (Mo’tamedi et al.). Given these promising but limited findings, 
continued research is needed to clarify the role of acceptance in primary headache disorders and 
further assess relations with pain-related functioning.  
Goals and Hypotheses of the Present Study  
The purpose of the present study was to investigate the relationship between general 
psychological acceptance and headache status and headache-related disability, frequency, and 
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severity in a young adult sample. A college sample was chosen because migraine is highly 
prevalent during the young adult years (Bigal, Bigal, Betti, Bordini, & Speciali, 2001; Lipton et 
al., 2007), associated with significant impairment in functioning and quality of life among these 
individuals (Smitherman, McDermott, & Buchanan, 2011), and because the headache 
presentations of younger sufferers are rarely confounded by medication overuse. Consistent with 
findings within the broader chronic pain literature (Chiros & O’Brien, 2011; McCracken, 1998; 
McCracken & Vowles, 2008; McCracken et al., 2004; McCracken & Zhao-O’Brien, 2010), the 
following goals and hypotheses were proposed: 
Study Goal 1: To examine acceptance across headache diagnostic groups. 
Hypothesis 1a: Individuals with primary headache conditions would demonstrate lower 
acceptance than those without headache. 
Hypothesis 1b: Differences in acceptance would remain after controlling for relevant 
covariates (e.g., gender and depression/anxiety symptomatology).  
Study Goal 2: To examine relations between acceptance and headache-related disability, 
severity, and frequency. 
Hypothesis 2a: Among only those with headache, acceptance would significantly predict 
headache-related disability, severity, and frequency (i.e., higher acceptance would be 
associated with lower headache disability, severity, and frequency).  
Hypothesis 2b: Acceptance would remain a significant predictor of these headache 
variables after controlling for relevant covariates. 
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METHODS 
Participants  
Undergraduate students 18 years of age or older comprised the study sample. These 
participants fulfilled ICHD-II diagnostic criteria for chronic migraine (CM), episodic migraine 
(EM with or without aura), ETTH, or chronic TTH (CTTH), as well as individuals who did not 
experience headache (i.e., non-headache controls). Because younger adult migraineurs often 
experience otherwise prototypical migraine attacks that last less than 4 hours (Rains, Penzien, 
Lipchik, & Ramadan, 2001; Rasmussen, Jensen, & Olseen, 1991), the ICHD-II minimum 
migraine duration criterion were shortened from 4 hours to 2 hours. Assuming a moderate effect 
size (f = .25), a power level of 0.80, and an alpha level of 0.05, a total sample size of 200 
participants was required. 
Materials 
Structured Diagnostic Interview for Headache – Revised. The Structured Diagnostic 
Interview for Headache – Revised (SDIH-II; Andrew, Penzien, Rains, Knowlton, & McAnulty, 
1992) is a computerized structured headache diagnostic interview that assesses the presence of 
primary headache disorders in strict accordance with ICHD-II criteria. The 17 items inquire 
about headache type, frequency, pain severity, and other diagnostic characteristics and 
symptomatology. The SDIH-II also provides information about the experience of aura symptoms 
and cluster headaches and can be used to rule out secondary causes such as posttraumatic 
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headache (i.e., directly attributable to a head injury) and medication overuse. The original SDIH 
is accurate in identifying migraine in both clinical and non-clinical populations; the SDIH-R 
includes minor revision to comport with ICHD-II diagnostic criteria. The SDIH-R is reprinted in 
Appendix A.  
Acceptance and Action Questionnaire-II. The Acceptance and Action Questionnaire-II 
(AAQ-2; Hayes et al., 2004; Bond, Hayes, Baer et al., 2011) is a 7-item measure that assesses the 
construct of general psychological acceptance. Items reflect the respondents’ willingness to 
remain in contact with private experiences such as emotions, thoughts, bodily sensations, or 
urges without attempting to alter or avoid them. (Sample items include: ‘‘It’s OK if I remember 
something unpleasant,” and ‘‘I worry about not being able to control my worries and feelings”). 
Items incorporate Likert-type responses from 1 (never true) to 7 (always true), with lower scores 
indicating greater psychological acceptance. The AAQ-II is internally consistent, demonstrates 
expected correlations with measures of avoidant coping and emotional distress (Bond et al.), and 
has demonstrated reliability and validity among patients with chronic pain (McCracken and 
Zhao-O’Brien, 2010). The mean alpha coefficient across six standardization samples is .84 (.78–
.88), and the 3- and 12-month test–retest reliabilities are .81 and .79, respectively (Bond et al.). 
The AAQ-II is reprinted in Appendix B. 
Headache Impact Test. The Headache Impact Test (HIT-6; Kosinski, Bayliss, & 
Bjourner, 2003) is a self-report measure used to assess headache-related disability. This brief 
measure is reliable and valid for use in screening and monitoring patients’ headaches in clinical 
research. High reliability has been demonstrated with internal consistencies ranging from .82 
to .92, and test-retest reliability was good at .77 (Kosinski et al.). The HIT-6 is a valid tool for 
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differentiating headache impact across diagnostic and headache severity groups (Yang, Rendaus-
Baum, Varon, & Kosinski, 2010). The HIT-6 is reprinted in Appendix C. 
Depression Anxiety Stress Scale. The 21-item version of the Depression Anxiety Stress 
Scale (DASS-21; Lovibond & Lovibond, 1995) is a reliable and valid measure used to assess 
changes in negative affective states. The DASS-21 has been used successfully among a variety 
of samples, including adolescents (Willemsen, Markey, Declercq, & Vanheule, 2010), inpatient 
clinical groups (Ng et al., 2007), elderly pain patients (Wood, Nicholas, Blyth, Asghari, & 
Gibson, 2010), and undergraduate college students (Osman et al., 2012). This measure contains 
three subscales pertaining to Depression (i.e., characterized by a loss of self-esteem and incentive, 
and low perceived probability of attaining subjectively important life goals), Anxiety (i.e., 
enduring state of anxiety and the acute response to fear), and Stress (i.e., state of persistent 
arousal and tension). In a college sample, reliability for the DASS-21 subscales have been found 
to be good at α = 0.85 for the Depression subscale, α = 0.81 for the DASS-Anxiety subscale, and 
α = 0.88 for the Stress scale (Osman et al.). The DASS-21 subscales have demonstrated good 
convergent validity with scales assessing similar constructs (Norton, 2007; Antony, Bieling, Cox, 
Enns, & Swinson, 1998; Lovibond & Lovibond; Osman et al.). The DASS-21 is reprinted in 
Appendix D.  
Procedure. Individuals included in the study completed the aforementioned measures as 
part of a larger online survey battery in exchange for modest course credit. Participants who 
denied experiencing headache comprised the non-headache control group. Individuals who 
experienced cluster headache, secondary headaches due to head injury, or medication overuse 
were excluded, as were those who reported headache but whose headache diagnosis could not be 
adequately determined. Survey respondents were also excluded from this study if they did not 
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complete the entire battery or evidenced suspect effort (i.e., defined as completing the 600+ item 
survey in less than 30 minutes, or above the 90
th
 percentile of completion time; see Smitherman 
& Kolivas, 2013).  
Statistical Analyses. Data were first checked for violation of statistical assumptions. 
Pearson correlations (for continuous variables) and chi-squared analyses (for gender) were 
utilized to assess potential relationships among gender, depression symptomatology, anxiety 
symptomatology, headache-related disability, headache severity, and headache frequency. These 
analyses were conducted to identify covariates for subsequent analyses. An ANOVA was 
utilized to determine if differences in psychological acceptance existed among the various 
headache and non-headache groups. A similar ANCOVA, using previously-identified covariates, 
was used to determine if any observed differences remained after controlling for other variables 
related to acceptance. Next, three individual linear regressions were performed to examine 
whether acceptance “predicted” headache-related disability, severity, and frequency, which were 
also repeated after controlling for relevant covariates.  
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RESULTS 
 Data Analytic Assumptions. Preliminary analyses of the data revealed violations of 
statistical assumptions relevant to obtaining valid results of the parametric tests. Specifically, the 
Levenne, Welch, and Brown-Forsythe statistics were significant (p < 0.05) and thus revealed 
violation of the assumptions of normality and equal variances of AAQII scores between those 
who endorsed headache and those who did not. Therefore, the data were transformed 
logarithmically per the recommendations of Tabachnick and Fidell (2007) and Howell (2007). 
Statistical analyses were executed on both the original and transformed data, but there were no 
significant differences in the results. Hence, only analyses with the original (i.e., non-
transformed) data are reported. Levenne’s statistic indicated that the data violated the assumption 
of equal variances of AAQII scores between those who endorsed headache and those who did 
not. Therefore, results of Levenne’s test are reported when equal variances were not obtained. 
Demographics and Descriptive Statistics. The initial sample was comprised of 4,723 
participants. Many of these participants were excluded from further evaluation as they did not 
provide headache data (n = 544), failed to complete the entire battery (n = 337), were less than 
18 years of age (n = 18), or evidenced suspect effort (n = 472). Upon examining the remaining 
3,352 participants’ data, additional participants were excluded as they reported cluster headache 
(n = 44), secondary headache due to head injury (n = 131), medication overuse headache (n = 6), 
or whose headache data were incomplete or precluded a clear headache diagnosis (n = 1,166).  
The retained sample included 2,005 participants, was predominantly female (n=1297; 64.7%), 
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and had a mean age of 19.10 (SD = 2.27), with a range of 18 to 55 years. Regarding ethnicity, the 
majority of the sample identified as White (79.1%), followed by African American (14.6%), 
Asian (2.1%), Multiracial (1.8%), Hispanic or Latino (1.8%), and other ethnicities (0.6%). 
Among individuals with headache, the average headache frequency was 6.39 days per month 
(SD = 5.38) and average headache severity was 4.61 (SD = 1.81) on a 10-point scale. Regarding 
headache diagnostic status, 839 (42.0%) of the sample evidenced no headache diagnosis, 107 
(5.3%) CM, 341 (17.0%) EM without Aura, 154 (7.7%) EM with Aura, 36 (1.8%) CTTH, and 
538 (26.3%) ETTH (see Table 1). 
Acceptance, Headache-Related Variables, and Psychiatric Symptoms. Sixty-five 
participants with headache diagnoses lacked AAQ-II data and were excluded from statistical 
analyses involving the AAQ-II. Correlation analyses among the entire sample indicated 
significant correlations between acceptance and many of the variables of interest. Specifically, 
depression (r = 0.54, p < 0.001) and anxiety (r = 0.49, p < 0.001) symptomatology were strongly 
correlated with acceptance, such that higher AAQ-II scores (lower acceptance) were associated 
with higher reports of depression and anxiety symptoms. Moreover, a point biserial correlation 
indicated that gender was significantly correlated with acceptance (rpb= 0.08; p<0.001), such that 
males evidenced greater acceptance (i.e., lower AAQ-II scores) than females (M = 17.96 vs 
19.41, respectively; t (1,938) = 3.505). As such, gender, depression and anxiety symptomology 
were used as covariates in subsequent analyses.  
Regarding diagnostic subgroup differences, the omnibus ANOVA indicated a significant 
main effect for acceptance as a function of diagnostic status, F(5, 1934) = 22.43, p < 0.001. 
Tukey HSD post-hoc tests revealed many significant differences in acceptance among the 
headache and non-headache diagnostic subgroups (see Table 2). Non-headache controls and 
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participants with ETTH had the highest levels of acceptance (i.e., lowest scores on the AAQ-II), 
and the lowest levels of acceptance were exhibited by those who experienced EM with Aura, CM, 
and CTTH, who did not differ significantly from one another. However, the ANCOVA 
controlling for gender, depression, and anxiety among these diagnostic subgroups revealed that 
the main effect of acceptance remained statistically significant for fewer subgroups after 
accounting for these covariates, F(5, 1854) = 4.47, p < 0.001, although the effect size was quite 
small (partial η2= 0.01). Specifically, after considering gender and psychiatric symptomatology, 
subgroup differences in acceptance only remained between non-headache controls and those 
with either EM without Aura or CM (see Table 3). 
 Results of the linear regression analyses among those with a headache diagnosis indicated 
that acceptance was significantly associated with each of the headache-related variables. 
Specifically, lower scores on the AAQ-II (i.e., higher levels of acceptance) were associated with 
less headache-related disability (B = 0.311, p < 0.001), headache severity (B = 0.043, p < 0.001), 
and headache frequency (B = 0.133, p < 0.001). Acceptance explained 10% of the variance (p < 
0.001) in headache-related disability, and 5% of the variance in both headache severity (p < 
0.001) and headache frequency (p < 0.001). Additionally, after controlling for covariates, greater 
acceptance remained a statistically significant, yet modest, “predictor” of less headache-related 
disability, accounting for 1.6% of incremental variance (β = 0.16, p < 0.001). General 
psychological acceptance also accounted for modest unique proportions of variance in headache 
severity (ΔR2 = 0.01, β = 0.14, p < 0.001) and headache frequency (ΔR2 = 0.01, β = 0.09, p < 
0.05). 
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DISCUSSION 
 The current study examined relationships between general psychological acceptance and 
headache-related variables (i.e. headache-related disability, headache severity, and headache 
frequency) among a young adult sample of headache sufferers. This is a population of interest 
because of their high prevalence of migraine and ETTH (Bigal, Bigal, Betti, Bordini, & Speciali, 
2001); associated impairment in academic performance and quality of life (Bigal, Bigal, Betti, 
Bordini, & Speciali, 2001; Smitherman, McDermott, & Buchanan, 2011); and because the 
headache histories of younger sufferers are unlikely to be complicated by years of medication 
overuse.  
Acceptance scores distinguished among those with and without headache, and among 
headache diagnostic groups. In the present study, the presence of any headache disorder other 
than ETTH, was associated with less general psychological acceptance compared to those 
without headache. Consistent with Dindo and colleagues’ (2012) finding that acceptance of 
headache pain was associated with reduced headache-related disability, greater general 
psychological acceptance was observed among those with the less frequent and disabling 
diagnosis of ETTH. Ancillary analyses supported the distinction that our ETTH sufferers had 
less severe head pain than those with migraine (p < 0.001), as well as significantly less headache-
related disability than the other headache groups (p < 0.001). Additionally, regardless of 
headache diagnosis, psychological acceptance was most strongly related to headache disorders 
involving a high frequency of attacks, such that individuals who experienced CTTH and CM 
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evidenced the lowest acceptance among the entire sample. Even after accounting for psychiatric 
symptomatology, significant differences in acceptance remained among some of the headache 
diagnostic groups. This suggests that acceptance may be an important factor when considering 
the quality of life of individuals who experience headaches, as our data demonstrated that 
individuals who experience headache have a greater propensity to dwell on past aversive 
experiences, which is associated with negative impact on engagement in many areas in life (e.g. 
functioning at work, school, and home). Notably, this propensity was greatest among those with 
headache conditions characterized by high-frequency attacks.  
 The construct of psychological acceptance per se has not been examined in the context of 
a headache sample. However, researchers examining general psychological acceptance in a 
general chronic pain sample observed that psychological acceptance contributed to patient 
functioning independent of acceptance of pain itself (McCracken & Zhao-O’Brien, 2010). 
General psychological acceptance and acceptance of pain are two differing constructs that may 
have different contributions to the functioning of individuals experiencing pain conditions. For 
instance, McCracken and Martinez (2011) examined the underlying processes of psychological 
flexibility and concluded that general psychological acceptance had both a significant and unique 
role in improvement of chronic pain patients’ functioning beyond those accounted for by 
acceptance of pain. As acceptance of pain has a narrow focus on individuals’ attitudes towards 
pain only, general acceptance denotes individuals’ willingness to experience a broader array of 
psychological events (e.g. aversive thoughts and bodily sensations). This distinction may be 
important in the experience of disability related to headaches, as experiential avoidance of 
phenomena less overtly related to pain may prompt greater and more frequent avoidance 
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behaviors. Taken together, these findings illuminate general psychological acceptance as a 
distinctly relevant construct to explore in chronic pain samples.  
Acceptance has garnered empirical support as a relevant construct within the broader 
chronic pain literature (Chiros & O’Brien, 2011; McCracken, 1998; McCracken & Vowles, 
2008; McCracken, Vowles, & Eccleston, 2005; McCracken et al., 2004; McCracken & Zhao-
O’Brien, 2010; Veehof, Oskam, Schreurs, & Bohlmeijer, 2011), and acceptance-based 
treatments have been associated with less headache-related disability in headache samples 
(Dindo et al., 2012; Mo’tamedi et al., 2012).  In investigating the effects of a guided internet-
delivered ACT intervention for individuals with chronic pain, Burhman and colleagues (2013) 
found increases in acceptance of chronic pain among a small subsample of headache sufferers, 
which were also associated with reduced pain-related distress, anxiety, and depressive symptoms. 
Overall, acceptance-based interventions appear both efficacious and effective in reducing pain as 
well as psychiatric symptoms among individuals with chronic musculoskeletal pain. Similar to 
studies on acceptance among chronic pain samples, this study provides support for a role of 
general psychological acceptance among those with a variety of primary headache disorders.  
Greater general psychological acceptance was indeed significantly associated with less 
headache-related disability, severity, and frequency across all headache sufferers, although the 
effect sizes were modest. The ACT headache treatment studies in the literature thus far have not 
measured general psychological acceptance, so there is no way of examining whether general 
acceptance levels changed during the course of treatment in these studies (Dindo et al., 2012; 
Mo’tamedi et al., 2012). Although a negative association between acceptance and the headache 
variables was observed, the modest results from the current study raise the possibility that 
general psychological acceptance may be less relevant than other constructs in accounting for 
24 
 
headache-related variables. Acceptance of pain specifically is perhaps a more relevant factor in 
chronic head pain, although we did not include a measure of pain acceptance for comparative 
purposes. Additionally, gender and psychiatric symptomatology accounted for greater variance 
in all of the headache-related variables than did acceptance, although both gender and psychiatric 
symptoms were associated with acceptance. Constructs such as locus of control and self-efficacy 
for managing pain may account for larger proportions of variance in headache variables than 
acceptance, although this hypothesis awaits empirical verification. Other possibilities are that 
general psychological acceptance operates as a partial mediator or moderator between headache 
and disability, or between headache pain and comorbid psychiatric symptomatology. Thus, while 
this study has shown a modest but significant role for psychological acceptance in headache, 
further studies are needed to explore the specific ways in which psychological acceptance 
impacts headache, changes as a function of treatment, and predicts clinically-relevant outcomes.     
Limitations and Future Directions  
 Although the present study contributes to the understanding of the role of psychological 
acceptance within the context of a headache sample, several methodological limitations exist. 
First, the current study utilized a cross-sectional research design and statistical methods that do 
not lend themselves to making inferences of causality. As such, changes in psychological 
acceptance may or may not produce changes in the other variables. A second limitation involves 
the fact the current study utilized a college sample of participants. Although these young adults 
provide benefits in terms of having less complicated headache histories than treatment-seeking 
older adults, findings may not generalize to the older or treatment-seeking headache populations. 
Stronger relations between acceptance and the headache variables might have been obtained had 
a more severe, treatment-seeking sample of headache patients been utilized. Finally, as 
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previously mentioned, the measure of acceptance used in this study is not specific to acceptance 
of chronic pain itself.  
 Perhaps if a measure of pain acceptance were utilized, such as the chronic pain 
acceptance questionnaire (CPAQ; McCracken, 1998), more robust results would have been 
observed and specific aspects of the experience of headache pain quantified. Assessing the utility 
of a measure such as the CPAQ in headache pain would prove valuable, as musculoskeletal pain 
involves differential influences of peripheral versus central nervous system processes. At present 
a measure of acceptance of headache pain does not exist; however, future studies could focus on 
developing such a measure as headache pain may be experienced differently than chronic 
musculoskeletal pain (e.g., headache pain is often more intermittent and unpredictable than 
musculoskeletal pain). Additionally, future research could utilize a longitudinal experimental 
design allowing for the manipulation of general psychological acceptance via brief analogue 
interventions or a more complete ACT-based protocol, in order to study directly the causal 
effects of altering acceptance on headache variables. Such a design would ideally employ a 
clinical sample of treatment-seeking headache patients of broader age groups and may yield 
favorable results regarding general acceptance and headache-related variables. As this study is 
the beginning of this line of research in headache, future designs can best clarify the role of 
acceptance in individuals with primary headache disorders. 
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Table 1 
Sample Demographics, Psychiatric Symptomatology, and Headache Diagnostic Status 
 No 
Headache 
Diagnosis 
n = 839 
(42%) 
 Migraine 
n = 602 
(30%) 
 Tension-
Type 
Headache 
n = 564 
(28%) 
 
  Chronic 
Migraine 
 
  
Episodic 
Migraine 
w/Aura 
Episodic 
Migraine 
w/o Aura 
Chronic 
TTH 
 
  
Episodic 
TTH 
 
 
Age 19.00  
(2.19) 
19.02 
(1.67) 
19.42    
(3.25) 
19.04    
(1.72) 
19.17      
(1.65) 
19.24 
(2.50) 
Female 456 
(54.4) 
97 
(90.7) 
121 
(78.6) 
258 
(75.7) 
28 
(77.8) 
337 
(63.8) 
Caucasian 676 
(80.6) 
88 
(82.2) 
121 
(78.6) 
247 
(72.4) 
31 
(86.1) 
423 
(80.1) 
DASS-21 
Depression  
4.51 
(6.38) 
9.48 
(10.20) 
8.78 
(8.40) 
6.23 
(7.43) 
8.65 
(11.17) 
4.89 
(5.76) 
DASS-21  
Anxiety  
3.93 
(5.22) 
8.71 
(8.16) 
8.34 
(7.59) 
6.26 
(6.52) 
7.61 
(7.30) 
4.61 
(4.80) 
Headache 
Days/Month 
2.45 
(2.42) 
18.03 
(3.80) 
6.46  
(3.65) 
5.79  
(3.89) 
18.11  
(4.38) 
4.66 
(3.00) 
Headache 
severity (0-10) 
2.71 
(1.62) 
6.04 
(1.31) 
5.92 
(1.46) 
5.57 
 (1.63) 
4.39 
(1.40) 
3.85 
(1.26) 
Hit-6  42.39  
(6.15) 
60.86 
(6.61) 
59.70  
(7.46) 
55.93  
(7.98) 
55.29  
(7.63) 
47.48 
(7.07) 
Values are mean (SD) or frequency counts (%). 
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Table 2 
ANOVA Post-Hoc Results for AAQ-II Groups Means (SD) 
 No 
Headache 
Chronic 
Migraine 
 
 
Episodic 
Migraine 
w/Aura 
 
Episodic 
Migraine 
w/o Aura 
 
Chronic 
TTH 
 
 
Episodic  
TTH 
 
 
AAQ-II Score 17.23
a
  
(8.15) 
23.53
b
 
(10.45) 
22.42
bc
  
(9.23) 
20.47
c
 
(9.14) 
23.75
bc
 
(10.47) 
18.25
a
 
(7.89) 
Means with different superscripts differ significantly at p < .05 (Tukey HSD). 
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Table 3 
ANCOVA Results for AAQ-II Group Marginal Means Controlling for Gender, Depression and 
Anxiety Symptoms (SE) 
 No 
Headache 
Chronic 
Migraine 
 
 
Episodic 
Migraine 
w/Aura 
 
Episodic 
Migraine 
w/o Aura 
 
Chronic 
TTH 
 
 
Episodic  
TTH 
 
 
AAQ-II Score 18.13
a 
(0.26) 
20.53
bc
 
(0.74) 
19.91
abc 
(0.61) 
19.74
bc
 
(0.40) 
21.18
abc
 
(1.23) 
18.73
abc
 
(0.32) 
Estimated marginal means with different superscripts differ significantly at p < .05. 
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Structured Diagnostic Interview for Headache – Revised (Brief Version) 
 
Patient Name: Age:  Sex:     M         
F 
 
Patient ID: Interviewer:  Date:        /       / 
 
 
The following items are selected from the long version of the Structured Diagnostic Interview 
for Headache (SDIH). The SDIH is part of the Headache Evaluation and Diagnostic System 
(HEDS) which includes software for data entry and diagnostic decision-making. These 
materials are intended to facilitate diagnosis of selected recurrent, benign headaches according 
to both IHS (2004) and Ad Hoc Committee (1962) diagnostic criteria. Optimal use of this 
interview requires expertise with the diagnostic classifications and familiarity with the 
computer software and manual that accompany the interview. 
 
 
  1. Does the patient get more than one type of headache?    Yes    No 
 (Complete a separate brief interview form for each type of headache)       Headache   
#1   #2   #3 
 
  2. Select all pain locations that apply to this type of headache: (You must check at least one) 
 
        frontal (A)      temporal (B)     occipital (C)     orbital (D)      supraorbital 
(E) 
 
  3. Select all that apply:  top of head (F)      base of neck (G)      nasal/facial (H) 
 
  4. What is the intensity of pain that the patient experiences with a typical headache?   ____ 
(Indicate rating from 0-10) 
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   0         1             2             3             4             5             6             7             8                9             10                            
  No                                Slightly                    Mildly                      Very                          Extremely 
  Pain                                Painful                    Painful                   Painful                         Painful 
 
     5. Which of the following symptoms are a “predominant feature” of this headache type 
(presume that the headache is untreated)? 
   
  Pain Location (Select only one):  Unilateral  Not Unilateral    
 
  Pain Features (Select only one):  Pulsating  Pressing/Tightening (non-
pulsating)  Other  
 
  6. How often does the patient experience this type of headache pain?   ____ d w m y  
(Indicate frequency in x per day, week, month, or year) 
 
  7. How long have these headaches been occurring at this rate?   ____ months  years 
  8. What is the total number of this type of headache ever experienced:    1    2-4   5-9   
 >10  ____  
(Indicate total number experienced) 
  9. How long does this headache last if untreated or unsuccessfully treated? (If patient falls 
asleep and wakes up without headache, duration of attack is until waking up. Check 
unremitting if patient reports never experiencing headache less than 7 days in duration). 
(Indicate duration in minutes, hours, or days)  
 
  Unremitting OR 
 
____ m h d  Typical Average               ____ m h d  Typical Minimum               ____ m 
h d  Typical Maximum 
 
10. Has anything about this headache (except freq.) changed in the last 6 months?    Yes   
 No 
 If YES, explain:              
              
 
11. Is the patient’s typical headache pain aggravated by routine physical activities (i.e., walking, 
lifting, bending, etc.)?  
 Yes   No 
       
12. Do any of the following symptoms occur with this headache?  
 
 Loss of appetite/Anorexia 
 Headache worsened by conversational noise levels (phonophobia) 
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 Headache worsened by normal light (photophobia) 
 Nausea (Indicate intensity)  Mild    Moderate    Severe                 
 Vomiting (Indicate intensity)   Mild    Moderate    Severe                   
   
13. Does the patient ever experience symptoms before this headache pain begins?    Yes   
 No 
If YES, and if any of the reported symptoms provide evidence of focal cerebral cortical, 
and/or brainstem                   dysfunction, complete Appendix 1 
If NO, skip to #14 
 
14. Does this headache have severe unilateral orbital, supraorbital, and/or temporal pain, and/or 
does the interviewer suspect a cluster-type headache?   Yes    No 
 If YES, complete Appendix 2 
 If NO, skip to #15 
 
15. Does the patient use any medications to relieve headache pain?    Yes    No 
  If YES, complete #15a, #15b, #15c 
  If NO, skip to #16 
 
 15a. How long has the patient been using the medication(s) to relieve headache pain?   
____ d w m y  
(Indicate duration in days, weeks, months, or years) 
 
 15b. What is the frequency of medication use?   ____days per week    ____days per month    
____ times per day 
 
 15c. Did this headache develop or markedly worsen during medication overuse?    Yes   
 No 
 If YES, complete Appendix 3 
If NO, skip to #16  
 
16. Is this headache related to any head injury or trauma?    Yes    No 
 If YES, complete Appendix 4 
 If NO, skip to #17 
 
17. Is this headache suspected to be attributed to a physical or other neurological disorder?    
Yes    No 
APPENDIX 1 Migraine Aura Symptoms 
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1. How many aura attacks has the patient experienced? ____ 
 
2. What best describes the aura symptoms? (Select all that apply) 
 At least one aura symptom develops gradually over more than 4 minutes, AND/OR 
2 or more symptoms  
     occur in succession over 4 minutes 
 Each aura symptom lasts longer than 4 minutes but less than 60 minutes 
 Headache begins during aura OR follows aura with a headache-free interval of less 
than 60 minutes 
 
3. Indicate which of the following aura symptoms are present during this type of headache: 
(Select all that apply) 
 
 X SYMPTOM 
 
X 
SYMPTOM 
 Partial loss of sight (scotoma)  Uncoordinated movements (ataxia) 
 Scintillation  Dizziness (vertigo) 
 Blurred vision  Ringing in ears (tinnitus) 
 Fortification spectra (zig-zag lines)  Decreased hearing acuity 
 Double vision  Decreased level of consciousness 
 Tingling or numbness (paresthesias)  Aphasia or unclassifiable speech 
 Weakness (paresis)  Poorly articulated speech (dysarthria) 
 Other:   Other:  
 
APPENDIX 2 Cluster Headache Symptoms 
 
 
1. Have the headaches occurred in cluster periods?    Yes    No 
If YES, complete #1a 
If NO, skip to #2 
 
     1a. What is the total number of cluster periods experienced?   ____  
 
1b. What is the duration of cluster periods?   ____ d w m y (Indicate duration in days, 
weeks, months, or years) 
 
2. Are the headaches separated by remission periods?    Yes    No 
If YES, complete #2a 
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If NO, skip to #3 
 
2a. What is the duration of remission periods?   ____ d w m y (Indicate duration in days, 
weeks, months, or years) 
 
3. Indicate which of the following symptoms are present, as well as side affected, during this 
type of headache: (Select all  
      that apply)  
 X SYMPTOM 
SID
E 
 
X 
SYMPTOM SIDE 
 Red eyes (conjunctival injection) 
R     
L 
 Forehead and facial sweating R     L 
 Tearing of the eyes (lacrimation) 
R     
L 
 Pupillary constriction (miosis) R     L 
 Nasal congestion 
R     
L 
 Drooping eyelids (ptosis) R     L 
 Runny nose (rhinorrhoea) 
R     
L 
 Eyelid swelling (oedema) R     L 
 Restlessness or agitation   Other:   
 
APPENDIX 3 Medication-Overuse Headache Symptoms 
 
1. Has the patient withdrawn from the overused medication?    Yes    No 
 If YES, complete #1a and #1b 
 If NO, skip to #2 
 
1a. Did headache resolve or revert to its previous pattern within 2 months after 
discontinuation of overused medication?  
 Yes    No 
 
1b. Has medication overuse ceased within the last 2 months, but headache has not resolved 
or reverted back to its previous pattern?    Yes   No 
 
2. Has intake of ergotamine, triptan, opioid OR combination of ergotamine, triptan, opioid, or 
analgesic occurred on 2 or more days per week, for 10 or more days per month, for 
greater than 3 months (Must not have combination overuse of any single class alone)?   
 Yes    No 
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If YES, indicate drug(s):     ergotamine    triptan    opioid    analgesic 
_____________________    
  
3. Has the patient’s intake of analgesic occurred on 2 or more days per week, for 15 or more 
days per month, for greater than 3 months?    Yes    No  
If YES, indicate drug: _____________________  
 
4. Has the patient’s intake of combination analgesics occurred on 2 or more days per week, for 
10 or more days per month, for greater than 3 months?     Yes    No 
 
                If YES, indicate drugs: 
_______________________________________________________________ 
  
5. Has the patient’s intake of medication other than ergotamine, triptan, analgesic, or opioid 
occurred on a regular basis for greater than 3 months?   Yes    No 
                If YES, indicate drug: _____________________ 
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APPENDIX 4 Post-Traumatic Headache Symptoms 
 
 
1. Was there a loss of consciousness associated with head trauma?    Yes    No   
 If YES, complete #1a 
 If NO, skip to #2 
 
1a. What was the duration of unconsciousness?   ____ m h d (Indicate duration in minutes, 
hours, or days) 
 
2. Is head injury attributed to whiplash?    Yes    No 
 If YES, skip #5 through #8  
       If NO, complete #3 through #8 
 
3. Did headache develop within 7 days after head trauma (or after regaining consciousness)?   
 Yes    No 
 
4. How long has the headache continued? (Select most representative category) 
  Resolves within 3 months after head trauma 
  Persists for greater than 3 months after head trauma 
  Persists but 3 months have not passed since head trauma 
 
5. Did coma develop?    Yes    No  
 If YES, indicate severity on Glasgow Coma Scale:    GCS <13 [moderate/severe]   
 GCS >13 [mild]       
 
6. Did post-traumatic amnesia develop and continue for longer than 48 hours?    Yes    
No 
 
7. Did symptoms/signs develop diagnostic of a concussion?     Yes    No 
 
8. Were abnormal neuroimaging results attained suggestive of a traumatic brain lesion?    
Yes   No 
 
©2007 Donald B. Penzien, Emily J. Bartley, Jamie L. Rhudy, & Jeanetta C. Rains, Reprinted 
with permissio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX B: ACCEPTANCE AND ACTION QUESTIONNAIRE-2 
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AAQ-2 
Below you will find a list of statements. Please rate the truth of each statement as it applies to 
you. Use the following scale to make your choice: 
1-Never True, 2-Very Seldom True, 3-Seldom True, 4-Sometimes True, 5-Frequently True, 
6-Almost Always True, 7-Always True 
 
1. My painful experiences and memories make it difficult for me to live a life that I would value. 
2. I’m afraid of my feelings. 
3. I worry about not being able to control my worries and feelings. 
4. My painful memories prevent me from having a fulfilling life. 
5. Emotions cause problems in my life. 
6. It seems like most people are handling their lives better than I am. 
7. Worries get in the way of my success. 
 
 
 
 
 
 
 
 
 
Bond et al., 2011; in the public domain. 
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HIT-6 
This questionnaire was designed to help you describe and communicate the way you feel 
and what you cannot do because of headaches. 
 
To complete, please circle one answer for each question. 
 
 
1) When you have headaches, how often is the pain severe? 
 
    Never      Rarely      Sometimes         Very      Often      Always 
 
2) How often do headaches limit your ability to do usual daily activities including household      
    work, work, school, or social activities? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
3) When you have a headache, how often do you wish you could lie down? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
4) In the past 4 weeks, how often have you felt too tired to do work or daily activities because of  
    your headaches? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
5) In the past 4 weeks, how often have you felt fed up or irritated because of your headaches? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
6) In the past 4 weeks, how often did headaches limit your ability to concentrate on work or daily  
    activities? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
 
 
 
 
 
From Kosinski et al., 2003, in the public domain. 
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DASS-21 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the 
statement applied to you over the past week. There are no right or wrong answers. Do not spend 
too much time on any statement. The rating scale is as follows:  
0 Did not apply to me at all, 1 Applied to me to some degree, or some of the time,  
2 Applied to me to a considerable degree, or a good part of time,  
3 Applied to me very much, or most of the time 
1   I found it hard to wind down 
2   I was aware of dryness of my mouth 
3   I couldn’t seem to experience any positive feeling at all 
4   I experienced breathing difficulty (eg, excessively rapid breathing, breathlessness in the   
     absence of physical exertion) 
5   I found it difficult to work up the initiative to do things 
6   I tended to over-react to situations 
7   I experienced trembling (eg, in the hands) 
8   I felt that I was using a lot of nervous energy 
9   I was worried about situations in which I might panic and make a fool of myself 
10 I felt that I had nothing to look forward to 
11 I found myself getting agitated  
12 I found it difficult to relax 
13 I felt down-hearted and blue 
14 I was intolerant of anything that kept me from getting on with what I was doing 
15 I felt I was close to panic 
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16 I was unable to become enthusiastic about anything 
17 I felt I wasn’t worth much as a person 
18 I felt that I was rather touchy  
19 I was aware of the action of my heart in the absence of physical excertion (eg, sense of heart     
      rate increase, heart missing a beat) 
20 I felt scared without any good reason 
21 I felt that life was meaningless 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lovibond & Lovibond (1995); in the public domain.  
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